Crown Bioscience

Crown Bioscience is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology.

[Crown Bioscience @crownbioscience]

Over 7 years Bryan Miller has seen how close-knit the team is, which leads to faster problem-solving, sharper ideas, and natural collaboration.

At Crown, we encourage our people to support one another, challenge current practices and grow as individuals.

[Crown Bioscience @crownbioscience]

Our latest research from SITC 2026 presents a fast, high-content screening platform to assess immunotherapy responses.

Download the poster to explore comparative analyses of immunotherapy responses across patient-derived organoid co-culture models.

https://t.co/ndbTMCpBWd

[Crown Bioscience @crownbioscience]

🎙️Crown Bioscience is working to accelerate the adoption of New Approach Methodologies (NAMs) across drug discovery and development.

Our role in the @CPathInstitute NAMs Developer Coalition, will enhance oncology research.

Listen to the full episode: https://t.co/sU8dZF6TV7

[Crown Bioscience @crownbioscience]

Our IHC menu has a dedicated “Tumor Antigen / ADC Target” category, with markers like Claudin 18, B7H3, FOLR1, and Mesothelin ready to run on validated protocols.

If you don't see your target, let us know and we can validate it for you: https://t.co/owMcPhs7Za

[Crown Bioscience @crownbioscience]

Meet us at the @EORTC @NCICancerCtrl @AACR #ENASymp26!

Join us in Barcelona from November 18-20 at Booth 30. We're presenting 6 new scientific posters showcasing how our translational research solutions support advances in drug discovery.

https://t.co/EMkbRXeFGg

[Crown Bioscience @crownbioscience]

In this on-demand webinar, see how integrated breast cancer model systems can support oncology drug discovery from early in vitro screening through in vivo efficacy studies and translational strategy.

Watch the full video: https://t.co/o0ZnVFLLKJ

[Crown Bioscience @crownbioscience]

Our team were delighted to be at SITC 2026, showcasing some of our latest preclinical and translational oncology data.

You can view all of our scientific posters online and schedule a meeting with an expert to discuss your research needs: https://t.co/ndfJQoV9rx

[Crown Bioscience @crownbioscience]

Earlier today we announced we won the Drug Development Solution Award in the 2026 BioTech Breakthrough Awards! @John Gu, Chief Executive Officer and Chief Operating Officer commented on this achievement.

Read the full announcement: https://t.co/8eEBXzsaIa

[Crown Bioscience @crownbioscience]

📣We have been honored with the Drug Development Solution Award in the 2026 BioTech Breakthrough Awards!

The award recognizes our integrated antibody-drug conjugate (ADC) research and development platform.

Read the full announcement: https://t.co/ORC3SlMcGX

[Crown Bioscience @crownbioscience]

For Jessie Wang, working at Crown Bioscience means access to expertise, global perspectives, and a shared target.

When people share ideas across disciplines, the work becomes sharper and more resilient.

Helping our people develop as individuals strengthens our company.

[Crown Bioscience @crownbioscience]

3D organoid models better preserve tumor biology, including growth factor dependencies, opening new possibilities for screening beyond 2D systems.

OrganoidXplore™ is an assay-ready service that processes up to 250+ models in as little as 6 weeks: https://t.co/ciN2dcLtf1

[Crown Bioscience @crownbioscience]

Meet us at the @EORTC @NCICancerCtrl @AACR Symposium!

Join us in Barcelona from November 18-20 at Booth 30.

We're presenting 6 new scientific posters showcasing how our translational research solutions support advances in drug discovery.

https://t.co/rn1oJQnJPt

[Crown Bioscience @crownbioscience]

📣We are delighted to announce the appointment of Guy Sheets as Senior Vice President, Commercial.

Guy will lead Crown Bioscience’s global commercial strategy and drive growth. He has over 30 years of experience in the pharma and biotechnology industry.

https://t.co/MJQkDDJr7N

[Crown Bioscience @crownbioscience]

Can target expression help explain ADC activity and how does response translate in vivo?

Our matched breast cancer organoid and PDX series offers a way to explore these questions across models with a range of HER2 expression levels.

Learn more: https://t.co/g7AHbXumfV

[Crown Bioscience @crownbioscience]

Your biomarker target isn’t on our IHC menu? That’s not a dead end. Our pathology team can develop and validate IHC assays for new targets. Tell us what you’re working on: https://t.co/yuv45l3vHd

[Crown Bioscience @crownbioscience]

Join us at @sitcancer #SITC26, Booth 609 to discover how your research can gain from our expertise in immunotherapy development.

We are also excited to present 3 new scientific posters!

Schedule a meeting in advance and discover our posters: https://t.co/KTsN5MCyBg

[Crown Bioscience @crownbioscience]

🎙️New approach methodologies (NAMs) are not just a platform choice.

They generate data to better reflect patient biology, reduce reliance on animals, and improve decision quality in oncology development.

Listen to the full episode with @CPathInstitute: https://t.co/Pq0UrCXjX5

[Crown Bioscience @crownbioscience]

A multi-omics biomarker partner needs 3 capabilities:

✅Integrated Study Design
✅Functional Validation
✅Quality Infrastructure

Crown Bioscience connects data, biology, and quality planning before samples ever ship.

Learn more about our services: https://t.co/PBUxHjUCCu

[Crown Bioscience @crownbioscience]

Meet us at SITC 2026 Booth 609. We offer a complete suite of platforms for precise immunotherapy development like in vitro 2D/3D assays, pharmacology studies, and more.

We're also showcasing 3 new scientific posters. Schedule a meeting in advance: https://t.co/D4dcatmxEo

[Crown Bioscience @crownbioscience]

Our IHC Biomarker Menu is searchable, allowing you to filter 400+ validated markers by category, species, and platform, then export your shortlist.

Don’t see your target? Our labs can validate it - contact us today.

Learn more: https://t.co/ilcBjihmKk